TrialBMC cancer2020

A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.

Tomoshi Tsuchiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.